DeMong; Duane

Patent Applications and Registrations

Patent applications and USPTO patent grants for DeMong; Duane.The latest application filed is for "9-substituted amino triazolo quinazoline derivatives as adenosine receptor antagonists, pharmaceutical compositions and their use".

Company Profile

6.22.30

DeMong; Duane - Hanover MA
DEMONG; Duane - Boston MA US
DeMong; Duane - Kenilworth NJ US
DeMong; Duane - Somerset NJ

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
9-substituted Amino Triazolo Quinazoline Derivatives As Adenosine Receptor Antagonists, Pharmaceutical Compositions And Their Use App 20220220117 - Larsen; Matthew A. ; et al.	2022-07-14
9-substituted amino triazolo quinazoline derivatives as adenosine receptor antagonists, pharmaceutical compositions and their use Grant 11,312,719 - Larsen , et al. April 26, 2	2022-04-26
Substituted Amino Triazolopyrimidine And Amino Triazolopyrazine Adenosine Receptor Antagonists, Pharmaceutical Compositions And Their Use App 20220040184 - Brill; Zachary G. ; et al.	2022-02-10
Antidiabetic bicyclic compounds Grant 11,225,471 - Colletti , et al. January 18, 2	2022-01-18
Substituted Amino Triazolopyrimidine And Amino Triazolopyrazine Adenosine Receptor Antagonists, Pharmaceutical Compositions And Their Use App 20210395255 - Brill; Zachary G. ; et al.	2021-12-23
9-substituted Amino Triazolo Quinazoline Derivatives As Adenosine Receptor Antagonists, Pharmaceutical Compositions And Their Use App 20210107904 - Larsen; Matthew A. ; et al.	2021-04-15
Antidiabetic bicyclic compounds Grant 10,968,193 - Chen , et al. April 6, 2	2021-04-06
Antidiabetic Bicyclic Compounds App 20210094938 - Colletti; Steven L. ; et al.	2021-04-01
Compounds inhibiting leucine-rich repeat kinase enzyme activity Grant 10,954,240 - Dai , et al. March 23, 2	2021-03-23
Chromane, isochromane and dihydroisobenzofuran derivatives as mGluR2-negative allosteric modulators, compositions, and their use Grant 10,806,724 - Sebhat , et al. October 20, 2	2020-10-20
Antidiabetic bicyclic compounds Grant 10,662,171 - Chobanian , et al.	2020-05-26
CHROMANE, ISOCHROMANE AND DIHYDROISOBENZOFURAN DERIVATIVES AS mGluR2-NEGATIVE ALLOSTERIC MODULATORS, COMPOSITIONS, AND THEIR USE App 20190247374 - Sebhat; Iyassu K. ; et al.	2019-08-15
Chromane, isochromane and dihydroisobenzofuran derivatives as mGluR2--negative allosteric modulators, compositions, and their use Grant 10,335,399 - Sebhat , et al.	2019-07-02
[7,6]-fused bicyclic antidiabetic compounds Grant 10,131,651 - Chobanian , et al. November 20, 2	2018-11-20
[5,6]--fused bicyclic antidiabetic compounds Grant 10,100,042 - Chen , et al. October 16, 2	2018-10-16
Antidiabetic compounds Grant 10,059,667 - Chobanian , et al. August 28, 2	2018-08-28
Compounds Inhibiting Leucine-rich Repeat Kinase Enzyme Activity App 20180230152 - Dai; Xing ; et al.	2018-08-16
CHROMANE, ISOCHROMANE AND DIHYDROISOBENZOFURAN DERIVATIVES AS mGluR2-NEGATIVE ALLOSTERIC MODULATORS, COMPOSITIONS, AND THEIR USE App 20180085358 - Sebhat; Iyassu K. ; et al.	2018-03-29
Antidiabetic Bicyclic Compounds App 20170217918 - Chen; Helen ; et al.	2017-08-03
Antidiabetic Bicyclic Compounds App 20170217920 - Chobanian; Harry ; et al.	2017-08-03
[7,6]-fused Bicyclic Antidiabetic Compounds App 20170217942 - Chobanian; Harry ; et al.	2017-08-03
Compounds inhibiting leucine-rich repeat kinase enzyme activity Grant 9,718,818 - DeMong , et al. August 1, 2	2017-08-01
[5,6]-fused Bicyclic Antidiabetic Compounds App 20170210727 - Chen; Helen ; et al.	2017-07-27
Compounds inhibiting leucine-rich repeat kinase enzyme activity Grant 9,688,654 - Miller , et al. June 27, 2	2017-06-27
Antidiabetic Compounds App 20160332968 - Chobanian; Harry ; et al.	2016-11-17
Compounds inhibiting leucine-rich repeat kinase enzyme activity Grant 9,493,440 - Miller , et al. November 15, 2	2016-11-15
Compounds Inhibiting Leucine-rich Repeat Kinase Enzyme Activity App 20160289207 - DeMong; Duane ; et al.	2016-10-06
Compounds inhibiting leucine-rich repeat kinase enzyme activity Grant 9,440,952 - Miller , et al. September 13, 2	2016-09-13
Compounds inhibiting leucine-rich repeat kinase enzyme activity Grant 9,416,126 - Miller , et al. August 16, 2	2016-08-16
Compounds Inhibiting Leucine-rich Repeat Kinase Enzyme Activity App 20160200722 - DeMong; Duane ; et al.	2016-07-14
Compounds Inhibiting Leucine-rich Repeat Kinase Enzyme Activity App 20160009696 - Miller; Michael ; et al.	2016-01-14
Compounds Inhibiting Leucine-rich Repeat Kinase Enzyme Activity App 20160009689 - Miller; Michael ; et al.	2016-01-14
Compounds Inhibiting Leucine-rich Repeat Kinase Enzyme Activity App 20160009681 - Miller; Michael ; et al.	2016-01-14
Compounds Inhibiting Leucine-rich Repeat Kinase Enzyme Activity App 20160009682 - Miller; Michael ; et al.	2016-01-14
Substituted cyclopropyl compounds, compositions containing such compounds, and methods of treatment Grant 9,006,228 - Miller , et al. April 14, 2	2015-04-14
Substituted Cyclopropyl Compounds, Compositions Containing Such Compounds, And Methods Of Treatment App 20140128368 - Miller; Michael ; et al.	2014-05-08
Substituted imidazolones, compositions containing such compounds and methods of use Grant 8,633,231 - DeMong , et al. January 21, 2	2014-01-21
Substituted Imidazolones, Compositions Containing Such Compounds And Methods Of Use App 20130123315 - DeMong; Duane ; et al.	2013-05-16

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.